Journal of cardiothoracic and vascular anesthesia
-
J. Cardiothorac. Vasc. Anesth. · Aug 2008
Randomized Controlled Trial Comparative StudyFast-track anesthesia with remifentanil and spinal analgesia for cardiac surgery: the effect on pain control and quality of recovery.
To assess pain intensity and quality of postoperative recovery in patients given fast-track anesthesia and spinal analgesia versus patients treated with standard anesthesia. ⋯ Fast-track anesthesia combined with morphine-clonidine spinal analgesia controlled postoperative pain better and obtained a better QoR than conventional analgesia.
-
J. Cardiothorac. Vasc. Anesth. · Aug 2008
Randomized Controlled Trial Comparative StudyCardiac protection with volatile anesthetics in stenting procedures.
Myocardial ischemic damage is reduced by volatile anesthetics in patients undergoing coronary artery bypass graft surgery. The authors tested the hypothesis that low-dose sevoflurane could decrease perioperative myocardial damage, as measured by cTnI release, when compared with placebo, in patients undergoing interventional cardiology procedures. ⋯ Myocardial damage measured by cardiac troponin release was not reduced by the volatile anesthetic sevoflurane during interventional cardiology procedures in this study.
-
J. Cardiothorac. Vasc. Anesth. · Aug 2008
Comparative StudyClosed-loop control of consciousness during lung transplantation: an observational study.
To determine if propofol infusion can be steered automatically by using bispectral index (BIS) as a controller during lung transplantation. ⋯ Closed-loop control of consciousness by a computer during lung transplantation is clinically feasible.
-
J. Cardiothorac. Vasc. Anesth. · Aug 2008
Comparative StudyThe concentration-dependent contractile effect of methylene blue in the human internal mammary artery: a quantitative approach to its use in the vasoplegic syndrome.
To quantitate the contractile effect of methylene blue on isolated human internal mammary artery (IMA) as used in the vasoplegic syndrome. ⋯ Methylene blue caused concentration-dependent contraction in human IMAs. Furthermore, the inhibition of ACh-induced relaxation for 6 hours after the methylene blue challenge points out an additional mechanism (ie, receptor occupation). The concentration-dependent contractile effect of methylene blue justifies its use in the vasoplegic syndrome. The findings also suggest that the time course of contraction is longer than the exposure to methylene blue.